Morikawa H - Search Results

1

Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma.

Iida-Ueno A, Enomoto M, Uchida-Kobayashi S, Hagihara A, Teranishi Y, Fujii H, Morikawa H, Murakami Y, Tamori A, Thuy LTT, Kawada N. Iida-Ueno A, et al. Among authors: morikawa h. Cancer Chemother Pharmacol. 2018 Nov;82(5):857-864. doi: 10.1007/s00280-018-3681-x. Epub 2018 Sep 3. Cancer Chemother Pharmacol. 2018. PMID: 30178114

2

A complete response induced by 21-day sorafenib therapy in a patient with advanced hepatocellular carcinoma.

Hagihara A, Teranishi Y, Kawamura E, Fujii H, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N. Hagihara A, et al. Among authors: morikawa h. Intern Med. 2013;52(14):1589-92. doi: 10.2169/internalmedicine.52.9340. Epub 2013 Jul 15. Intern Med. 2013. PMID: 23857091 Free article. Review.

3

Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.

Kawamura E, Shiomi S, Kotani K, Kawabe J, Hagihara A, Fujii H, Uchida-Kobayashi S, Iwai S, Morikawa H, Enomoto M, Murakami Y, Tamori A, Kawada N. Kawamura E, et al. Among authors: morikawa h. J Gastroenterol Hepatol. 2014 Sep;29(9):1722-7. doi: 10.1111/jgh.12611. J Gastroenterol Hepatol. 2014. PMID: 24730671

4

Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.

Hai H, Tamori A, Thuy LTT, Yoshida K, Hagihara A, Kawamura E, Uchida-Kobayashi S, Morikawa H, Enomoto M, Murakami Y, Kawada N. Hai H, et al. Among authors: morikawa h. Sci Rep. 2017 Sep 19;7(1):11912. doi: 10.1038/s41598-017-10363-5. Sci Rep. 2017. PMID: 28928439 Free PMC article.

5

Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.

Motoyama H, Tamori A, Kubo S, Uchida-Kobayashi S, Takemura S, Tanaka S, Ohfuji S, Teranishi Y, Kozuka R, Kawamura E, Hagihara A, Morikawa H, Enomoto M, Murakami Y, Kawada N. Motoyama H, et al. Among authors: morikawa h. PLoS One. 2018 Mar 13;13(3):e0194163. doi: 10.1371/journal.pone.0194163. eCollection 2018. PLoS One. 2018. PMID: 29534101 Free PMC article.

6

Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.

Kozuka R, Enomoto M, Sato-Matsubara M, Yoshida K, Motoyama H, Hagihara A, Fujii H, Uchida-Kobayashi S, Morikawa H, Tamori A, Kawada N, Murakami Y. Kozuka R, et al. Among authors: morikawa h. J Gastroenterol Hepatol. 2019 May;34(5):937-946. doi: 10.1111/jgh.14454. Epub 2018 Sep 26. J Gastroenterol Hepatol. 2019. PMID: 30160782

7

Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma.

Kotani K, Enomoto M, Okada M, Yoshida K, Motoyama H, Fujii H, Hagihara A, Uchida-Kobayashi S, Morikawa H, Murakami Y, Tamori A, Kawada N. Kotani K, et al. Among authors: morikawa h. Clin J Gastroenterol. 2019 Aug;12(4):355-360. doi: 10.1007/s12328-019-00983-x. Epub 2019 Apr 24. Clin J Gastroenterol. 2019. PMID: 31020569

8

Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection.

Hayashi T, Tamori A, Nishikawa M, Morikawa H, Enomoto M, Sakaguchi H, Habu D, Kawada N, Kubo S, Nishiguchi S, Shiomi S. Hayashi T, et al. Among authors: morikawa h. Liver Int. 2009 Jan;29(1):126-32. doi: 10.1111/j.1478-3231.2008.01772.x. Epub 2008 May 19. Liver Int. 2009. PMID: 18492017

9

Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.

Tamori A, Hayashi T, Shinzaki M, Kobayashi S, Iwai S, Enomoto M, Morikawa H, Sakaguchi H, Shiomi S, Takemura S, Kubo S, Kawada N. Tamori A, et al. Among authors: morikawa h. J Med Virol. 2009 Jun;81(6):1009-14. doi: 10.1002/jmv.21488. J Med Virol. 2009. PMID: 19382258

10

Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C.

Morikawa H, Fukuda K, Kobayashi S, Fujii H, Iwai S, Enomoto M, Tamori A, Sakaguchi H, Kawada N. Morikawa H, et al. J Gastroenterol. 2011 Mar;46(3):350-8. doi: 10.1007/s00535-010-0301-x. Epub 2010 Aug 10. J Gastroenterol. 2011. PMID: 20697747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters